CJC-1295 / Ipamorelin

GHRH analogue combined with selective growth hormone secretagogue. Two-vial combination: CJC-1295 (DAC) 5mg and Ipamorelin 5mg. The most commonly co-studied GHRH/GHRP pairing in the literature.

98%+ purity 5mg each HPLC tested 2 vials included CoA published

$85 two-vial set · free shipping over $150

View Certificate of Analysis

Research purposes only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any condition. For laboratory and in vitro research use only. Must be 18+ to purchase.

About this combination

CJC-1295 / Ipamorelin

CJC-1295 (with DAC) is a modified form of growth hormone releasing hormone (GHRH). The drug affinity complex (DAC) modification enables albumin binding, extending plasma half-life in research models compared to native GHRH. It is one of the most widely studied GHRH analogues in the published literature.

Ipamorelin is a selective growth hormone secretagogue receptor (GHSR) agonist and one of the most specific GHRPs studied in research contexts. Its selectivity for GHSR over other receptor subtypes is a frequently cited characteristic in the literature, distinguishing it from earlier generation GHRPs.

What I noticed when reviewing the literature on this combination was how consistently researchers pair these two compounds. The GHRH/GHRP synergy has been documented across a substantial number of published animal model studies, with researchers citing the complementary mechanisms as a rationale for dual-compound protocols.

My experience with the published research in this area shows that this pairing is one of the most protocol-ready combinations in the growth hormone research space. The volume of available reference literature makes it straightforward to design well-grounded experimental frameworks.

CJC-1295 (DAC)

GHRH analogue · 5mg
DAC modification for extended half-life in model systems

Ipamorelin

Selective GHSR agonist · 5mg
Pentapeptide GHRP with high selectivity profile

Storage

Lyophilised: -20°C, 24 months
Reconstituted: 2-8°C, 28 days each. Protect from light.

Purity

99.1%
HPLC verified · Batch #2607

Research Notes

What researchers have observed

What I noticed

This is the single most frequently cited GHRH/GHRP combination in the growth hormone research literature I reviewed. The CJC-1295 + Ipamorelin pairing appears across studies spanning multiple research groups and publication years, suggesting a well-established research rationale.

Mechanism pairing

My experience reviewing the literature consistently shows that researchers choose CJC-1295 and Ipamorelin together because they act on two distinct but synergistic pathways. CJC-1295 mimics GHRH while Ipamorelin acts on ghrelin receptors. The dual-pathway approach is cited as providing more complete model coverage than either compound alone.

Selectivity profile

What I noticed when comparing Ipamorelin to earlier GHRPs in the literature was its consistently cited selectivity advantage. Researchers frequently use it specifically because of its more targeted receptor profile, which simplifies the interpretation of experimental results.

Combination value

The two-vial set pricing reflects the typical research use case for this pairing. Purchasing them as a set versus individually saves on fulfilment and ensures both components come from the same independently verified batch, maintaining consistency across the research protocol.

DISCLAIMER: CJC-1295 and Ipamorelin are sold by Apex Research Labs strictly for in vitro and laboratory research purposes only. They are not intended for human consumption. They are not drugs, supplements, or food products. These products have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease or medical condition. You must be 18 years of age or older to purchase. By purchasing, you confirm that you are a qualified researcher using these compounds solely for lawful scientific research purposes and in compliance with all applicable local, state, and federal laws and regulations. Apex Research Labs assumes no liability for any misuse of these products.